| Brandi Janae Radtke, | |
|
2209 E Sooner Rd, Blanchard, OK 73010-6634 | |
| (405) 387-4880 | |
| Not Available |
| Full Name | Brandi Janae Radtke |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 2209 E Sooner Rd, Blanchard, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245961408 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | (* (Not Available)) | Secondary |
| 235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Brandi Janae Radtke, 2209 E Sooner Rd, Blanchard, OK 73010-6634 Ph: (405) 387-4880 | Brandi Janae Radtke, 2209 E Sooner Rd, Blanchard, OK 73010-6634 Ph: (405) 387-4880 |
News Archive
Advogent Group, Inc., a leading provider of sales and marketing solutions for the healthcare industry, today announced that it has signed a definitive agreement for field logistics services with Bristol-Myers Squibb Company (NYSE: BMY).
WNYC's Fred Mogul, working in partnership with Kaiser Health News and NPR, writes: "As a way to reduce the number of uninsured, states are being encouraged to set more generous income limits for Medicaid as part of the Affordable Care Act. If states comply, they can get 100 percent federal funding in the first three years, declining to 90 percent funding over time. Typically, states and the federal government share the burden at a ratio that's closer to 50-50."
Corcept Therapeutics Incorporated, a pharmaceutical company engaged in the discovery, development and commercialization of drugs that treat severe metabolic, oncologic and psychiatric disorders by modulating the effects of cortisol, today announced results of a multi-center Phase 1/2 dose-escalation study of mifepristone and chemotherapy drug eribulin (Halaven) that show it is well tolerated and clinically active in patients with triple-negative breast cancer.
Helix BioPharma Corp. announced today that its Phase II trial of Topical Interferon Alpha-2b for the treatment of ano-genital warts (AGW) has completed patient enrollment, with the required 120th patient randomized to enter the trial.
NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services, today reported its results for the second quarter of 2015.
› Verified 7 days ago
The Speech Easy Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 184 Summer Valley Rd, Blanchard, OK 73010 Phone: 405-201-3733 | |
Mrs. Lendy Kay Duncan, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 485 Summer Valley Rd, Blanchard, OK 73010 Phone: 580-317-5848 | |
Kristi York-bonds, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1605 Maple St, Blanchard, OK 73010 Phone: 405-708-1919 | |
Driskell Speech Services, Pllc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 400 Se 2nd St, Blanchard, OK 73010 Phone: 405-779-3270 Fax: 405-293-3500 | |
Ms. Andrea M Driskell, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 400 Se 2nd St, Blanchard, OK 73010 Phone: 405-779-3270 | |
Ashley Owens, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 400 Se 2nd St, Blanchard, OK 73010 Phone: 405-779-3270 Fax: 405-561-4806 | |
Molly Ann Ita, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 25252 Roselawn Rd, Blanchard, OK 73010 Phone: 405-485-3347 |